Biotech startup pulls in $187M to make ‘multi-payload’ ADCs

Biotech startup pulls in $187M to make ‘multi-payload’ ADCs

Submitted by admin on March 3, 2025 - 11:52pm
Source: 
BioPharma Dive
News Tags: 
Callio Therapeutics
antibody-drug conjugates
funding
Headline: 
Biotech startup pulls in $187M to make ‘multi-payload’ ADCs
snippet: 

Callio Therapeutics is debuting with an ADC technology and related programs licensed from Singapore-based antibody drug developer Hummingbird Bioscience.

Do Not Allow Advertisers to Use My Personal information